Rep. Josh Gottheimer Sells Haleon plc (NYSE:HLN) Shares

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Haleon plc (NYSE:HLN). In a filing disclosed on May 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Haleon stock on April 9th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of RTX (NYSE:RTX) on 4/23/2025.
• Purchased $1,001 – $15,000 in shares of Cheniere Energy (NYSE:LNG) on 4/22/2025.
• Purchased $1,001 – $15,000 in shares of Techtronic Industries (OTCMKTS:TTNDY) on 4/21/2025.
• Purchased $1,001 – $15,000 in shares of Tri Pointe Homes (NYSE:TPH) on 4/21/2025.
• Purchased $1,001 – $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of KKR & Co. Inc. (NYSE:KKR) on 4/21/2025.
• Purchased $1,001 – $15,000 in shares of D.R. Horton (NYSE:DHI) on 4/21/2025.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 4/21/2025.
• Sold $1,001 – $15,000 in shares of Hillman Solutions (NASDAQ:HLMN) on 4/17/2025.
• Sold $1,001 – $15,000 in shares of AbbVie (NYSE:ABBV) on 4/17/2025.

Haleon Stock Up 2.5%

Shares of Haleon stock opened at $10.66 on Friday. The business has a 50-day moving average of $10.21 and a 200-day moving average of $9.86. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market capitalization of $48.06 billion, a PE ratio of 31.35, a P/E/G ratio of 2.82 and a beta of 0.24. Haleon plc has a 1-year low of $8.25 and a 1-year high of $10.85.

Haleon (NYSE:HLN) last issued its earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The company had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. As a group, equities analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently declared a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a $0.1166 dividend. This is an increase from Haleon’s previous — dividend of $0.05. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. Haleon’s dividend payout ratio is currently 58.97%.

Institutional Investors Weigh In On Haleon

A number of hedge funds have recently made changes to their positions in HLN. FMR LLC raised its holdings in Haleon by 3.7% during the fourth quarter. FMR LLC now owns 108,827,814 shares of the company’s stock worth $1,038,217,000 after purchasing an additional 3,909,545 shares in the last quarter. Wellington Management Group LLP raised its holdings in Haleon by 22.0% during the first quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company’s stock worth $192,428,000 after purchasing an additional 3,372,155 shares in the last quarter. Sculptor Capital LP raised its holdings in Haleon by 22.1% during the first quarter. Sculptor Capital LP now owns 10,849,868 shares of the company’s stock worth $111,645,000 after purchasing an additional 1,962,770 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in Haleon by 0.8% during the fourth quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company’s stock worth $72,793,000 after purchasing an additional 58,444 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Haleon by 18.3% during the fourth quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company’s stock worth $57,382,000 after purchasing an additional 930,701 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HLN. HSBC restated a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Barclays restated an “overweight” rating on shares of Haleon in a research note on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Morgan Stanley raised Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 price target on the stock in a report on Friday, May 9th. Finally, Hsbc Global Res cut Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Five analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Haleon has an average rating of “Moderate Buy” and an average target price of $11.25.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.

Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.

Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.

Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.